Top Markets
Coin of the day
Elicio Therapeutics, Inc. Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTX
Peringkat dalam Saham #24601
Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to... Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.
Harga Saham
$3.09
Kapitalisasi Pasar
$58.82M
Perubahan (1 hari)
0.33%
Perubahan (1 tahun)
-73.01%
Negara
US
Perdagangan Elicio Therapeutics, Inc. (ELTX)

Kategori

Riwayat harga saham Elicio Therapeutics, Inc. (ELTX)
Harga penutupan tertinggi: $3.10 pada 2026-08-01

Harga penutupan terendah: $5.88 pada 2023-11-01
Riwayat harga saham Elicio Therapeutics, Inc. dari 2023 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 9.17%
2025 59.27%
2024 -21.55%
2023 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$550.26 38.44%
US
$1.05K 58.16%
NL
$148.90 467.89%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH